![](https://entrepreneurs.utoronto.ca/wp-content/uploads/2021/08/Immplacate_Alumni.png)
Immplacate
Immplacate is a preclinical-stage cell therapy company that is clinically developing educated mesenchymal cells (EMCs) for treatment of unwanted immune responses. Mesenchymal stromal cells (MSCs) are cells that can differentiate into a variety of other cell types.